Broadly neutralizing antibodies combined with latency-reversing agents or immune modulators as strategy for HIV-1 remission.

Current Opinion in HIV and AIDS
Jesper Damsgaard GunstOle Schmeltz Søgaard

Abstract

Antiretroviral therapy (ART) is extremely effective in controlling HIV-1 infection; however, ART is not curative. Here, we review broadly neutralizing anti-HIV-1 antibodies (bNAbs) combined with latency-reversing agents (LRAs) or immune modulators as strategy for achieving long-term HIV-1 remission. Clinical trials testing the effect of a single intervention such as a LRA 'shock and kill', immune modulator or bNAbs among HIV-1 infected individuals on long-term suppressive ART have not lead to long-term HIV-1 remission when ART is stopped. Novel combinations of interventions designed to eliminate infected cells and enhance immune-effector functions are being investigated. Findings in nonhuman primates (NHPs) of such combinations are very promising and clinical trials are now ongoing. These trials will provide the first indication of the efficacy of combinations of bNAbs and LRA or immune modulators for achieving durable HIV-1 remission. bNAbs facilitate the elimination of HIV-1 infected cells and boost immune responses. Preclinical findings show that these effects can be harnessed by simultaneous administration of LRAs or immune modulators such as Toll-like receptor agonists. The clinical success of such combination strategies m...Continue Reading

References

Jun 10, 2006·Nature Reviews. Drug Discovery·Arthur M Krieg
Nov 21, 2007·The Journal of Experimental Medicine·Galit AlterMarcus Altfeld
Apr 13, 2012·PLoS Pathogens·Jeanette ReeceMiles P Davenport
May 31, 2012·Immunotherapy·Holbrook E KohrtJoshua Brody
Jul 23, 2014·Annals of Internal Medicine·Timothy J HenrichDaniel R Kuritzkes
Sep 26, 2014·Journal of Virology·Janka PetravicMiles P Davenport
Mar 31, 2015·The Journal of Clinical Investigation·Gregory M LairdRobert F Siliciano
Sep 18, 2015·PLoS Pathogens·Ole S SøgaardMartin Tolstrup
Dec 23, 2015·Trends in Microbiology·Thomas Aagaard RasmussenOle Schmeltz Søgaard
Jul 12, 2016·Nature Medicine·Steven G DeeksJerome Zack
Nov 18, 2016·ELife·Johanna BrodinJan Albert
Mar 16, 2017·Nature·Yoshiaki NishimuraMalcolm A Martin
Mar 23, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Line VibholmOle S Søgaard
Aug 2, 2017·Cell·Joshua A HorwitzMichel C Nussenzweig
Jul 22, 2018·Advances in Experimental Medicine and Biology·Georges KhouryCarine Van Lint
Oct 5, 2018·Nature·Erica N BorducchiDan H Barouch
Oct 11, 2019·Science Translational Medicine·Melissa-Rose AbrahamsRonald Swanstrom

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Opinion in HIV and AIDS
Mar Naranjo-Gomez, Mireia Pelegrin
Current Opinion in Virology
Marloes GrobbenMarit J van Gils
Current Opinion in HIV and AIDS
Boris Julg, Dan H Barouch
© 2021 Meta ULC. All rights reserved